Privia Health (PRVA) shares were rising nearly 2% in recent Thursday trading after the company reported Q3 adjusted earnings of $0.20 per diluted share, up from $0.17 a year earlier.
That result matched the average estimate of analysts polled by Capital IQ.
Revenue for the quarter ended Sept. 30 was $437.9 million, up from $417.3 million a year earlier.
Analysts surveyed by Capital IQ expected $413.5 million.
The company said it now expects 2024 revenue at the "high end" of the guidance range between $1.60 billion and $1.68 billion. The previous guidance provided with Q2 results was "mid to high end" of that range.
Analysts surveyed by Capital IQ expect $1.67 billion.
Price: 21.70, Change: +0.54, Percent Change: +2.55
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。